Inventor
FOSTER ROBERT T
CA37 patents
⚠️ This page may combine multiple inventors who share the name “FOSTER ROBERT T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISOTECHNIKA INC
28 patentsUS7538189B2May 26, 2009
Methods of making deuterated cyclosporin analogs
ISOTECHNIKA INC237 citations99
US7521421B2Apr 21, 2009
Deuterated cyclosporine analogs and methods of making the same
ISOTECHNIKA INC237 citations99
US6503921B2Jan 7, 2003
Deuterated rapamycin compounds, methods and uses thereof
ISOTECHNIKA INC140 citations99
US6342507B1Jan 29, 2002
Deuterated rapamycin compounds, method and uses thereof
ISOTECHNIKA INC129 citations99
US6221335B1Apr 24, 2001
Method of using deuterated calcium channel blockers
ISOTECHNIKA INC607 citations99
US7118919B2Oct 10, 2006
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
ISOTECHNIKA INC122 citations98
US6613739B1Sep 2, 2003
Deuterated cyclosporine analogs and their use as immunomodulating agents
ISOTECHNIKA INC107 citations98
US6334997B1Jan 1, 2002
Method of using deuterated calcium channel blockers
ISOTECHNIKA INC549 citations98
US5846514ADec 8, 1998
Enhancement of the efficacy of nifedipine by deuteration
ISOTECHNIKA INC608 citations98
US7060672B2Jun 13, 2006
Cyclosporin analog formulations
ISOTECHNIKA INC64 citations97
US6998385B2Feb 14, 2006
Cyclosporine analogue mixtures and their use as immunomodulating agents
ISOTECHNIKA INC51 citations96
US6818200B2Nov 16, 2004
Method of using deuterated calcium channel blockers
ISOTECHNIKA INC45 citations95
US6605593B1Aug 12, 2003
Deuterated cyclosporine analogs and their use as immunomodulating agents
ISOTECHNIKA INC99 citations95
US6602715B2Aug 5, 2003
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
ISOTECHNIKA INC64 citations95
US6599750B2Jul 29, 2003
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
ISOTECHNIKA INC66 citations95
US6468802B1Oct 22, 2002
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
ISOTECHNIKA INC68 citations95
US6461870B2Oct 8, 2002
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
ISOTECHNIKA INC69 citations95
US7160867B2Jan 9, 2007
Rapamycin carbohydrate derivatives
ISOTECHNIKA INC54 citations93
US6333342B1Dec 25, 2001
Methods of pharmacological treatment using S(−) amlodipine
ISOTECHNIKA INC30 citations93
US7429562B2Sep 30, 2008
Cyclosporin analog formulations
ISOTECHNIKA INC15 citations92
US7332472B2Feb 19, 2008
Cyclosporine analogue mixtures and their use as immunomodulating agents
ISOTECHNIKA INC20 citations92
US7141648B2Nov 28, 2006
Synthesis of cyclosporin analogs
ISOTECHNIKA INC17 citations90
US7358229B2Apr 15, 2008
Deuterated cyclosporin analogs and their use as immunomodulating agents
ISOTECHNIKA INC7 citations74
US6476058B2Nov 5, 2002
Methods of pharmacological treatment using S(−) amlodipine
ISOTECHNIKA INC6 citations74
US7829533B2Nov 9, 2010
Cyclosporin analog formulations
ISOTECHNIKA INC7 citations73
US6878550B2Apr 12, 2005
13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
ISOTECHNIKA INC7 citations73
US6780995B2Aug 24, 2004
Activated iododerivatives for the treatment of cancer and aids
ISOTECHNIKA INC0 citations52
US6511988B2Jan 28, 2003
Activated iododerivatives for the treatment of cancer and aids
ISOTECHNIKA INC0 citations52
ISOTECHNIKA INTERNAT INC
3 patentsUS6884429B2Apr 26, 2005
Medical devices incorporating deuterated rapamycin for controlled delivery thereof
ISOTECHNIKA INTERNAT INC107 citations95
US6710053B2Mar 23, 2004
Deuterated rapamycin compounds, method and uses thereof
ISOTECHNIKA INTERNAT INC56 citations95
US6939878B2Sep 6, 2005
Deuterated rapamycin compounds, method and uses thereof
ISOTECHNIKA INTERNAT INC29 citations92
AURINIA PHARMACEUTICALS INC
3 patentsUS9765119B2Sep 19, 2017
Cyclosporine analogue mixtures and their use as immunomodulating agents
AURINIA PHARMACEUTICALS INC4 citations83
USRE48226ESep 29, 2020
Cyclosporine analogue mixtures and their use as immunomodulating agents
AURINIA PHARMACEUTICALS INC1 citations72
US10472394B2Nov 12, 2019
Cyclosporine analogue mixtures and their use as immunomodulating agents
AURINIA PHARMACEUTICALS INC2 citations72